Reconsideration of splenectomy for cirrhotic patients - Tracing the history and pitfalls

Kanzo/Acta Hepatologica Japonica

Volumn 51, Issue 5, 2010, Pages 205-218

  Ogata, Toshiro ^a   Kage, Masayoshi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Interferon; Liver cirrhosis; Post operative infection; Splenectomy

Indexed keywords

INTERFERON;

HISTORY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; POSTOPERATIVE INFECTION; REVIEW; SPLENECTOMY;

EID: 77953598021     PISSN: 04514203     EISSN: None     Source Type: Journal    
DOI: 10.2957/kanzo.51.205     Document Type: Review

References (124)

1. William WC. Splenectomy for thrombo-cytopenia due to secondary hypersplenism. Arch Surg 1988; 123: 369-371
2. Kercber KW, Carbonell AM, Heniford BT, et al. Laparoscopic splenectomy reverses thrombocyropenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastrointest Surg 2004; 8:120-126
3. Sugawara Y, Yamamoto J, Shimada K, et al. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 2000; 190:446-450 (Pubitemid 30181110)
4. Hashizume M, Tomikawa M, Akahoshi T, et al. Laparoscopic splenectomy for portal hypertension. Hepatogastroenterology 2002; 49: 847-852
5. Yagi S, Iida T, Hori T, et al. Optimal portal venous circulation for liver graft function after living-donor liver transplantaion. Transplantaion 2006; 81: 373-378 (Pubitemid 43255722)
6. Yoshizumi T, Taketomi A, Soejima Y, et al. The benefical role of simultaneous splenectomy in living donor liver transplantaion in patients with small-for-size graft. Transpl Int 2008; 21: 833-842
7. Waghorn DJ, Mayon-White RT. A study of 42 episodes of overwhelming post-splenectomy infection is current guidance for asplenic individuals being followed? J Infect 1997; 35: 289-294
8. Okabayashi T, Hanazaki K. Overwhelming postsplenectomy infection syndrome in adults - A clinical preventable disease. World J Gastroenterol 2008; 14:176-179 (Pubitemid 351320405)
9. Yoshida M, Watanabe Y, Horiuchi A, et al. Portal and splenic venous thrombosis after splenectomy in patients with hypersplenism. Hepatogastroenterology 2009; 56: 538-541
10. Park R. Splenectomy for leukaemic enlargement. Ann Surg 1888; 8: 380-383
11. Harris ML, Herzog M Splenectomy in splenic anaemia or primary splenomegaly. Ann Surg 1901; 34: 111-134
12. Dawson B. Enlarged Spleen; Cirrhosis of Liver; Splenectomy. Proc R Soc Med 1914; 7:105-106
13. No authors listed. Discussion on the indication for and the results of splenectomy. Proc R Soc Med 1929; 22:1493-1517
14. Myers B. Gaucher's Disease: Splenectomy. Proc R Soc Med 1932; 25:396-398
15. Evans RS, Duane R. Hemolytic anemias recent advances in diagnosis and treatment. Calif Med 1949; 70:244-251
16. Byrne RV. Splenectomy for idiopathic thrombocytopenic purpura. Am J Surg 1950; 79: 446-449
17. Filippini Battistelli U. Splenectomy in the Banti syndrome;immediately and late results. Riv Pathol Clin 1950; 5:149-160
18. Glenn F, Cornell GN, Smith CH, et al. Splenectomy in children with idiopathic thrombocytopenic purpura, hereditary spherocytosis, and Mediterranean anemia. Surg Gynecol Obstet 1954; 99: 689-702
19. Saubier EC, Lequin P, Gaillard P. Value of splenectomy in the surgical treatment of portal hypertension. Arch Fr Mai App Dig 1967; 56: 691-702
20. Hassab MA. Gastroesophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: further studies with a report on 355 operations. Surgery 1967; 61:169-176
21. Inoguchi K, Kobayashi M. Prognosis after surgical management of portal hypertension. Geka Chiryo 1969; 21: 563-576
22. Boye NP, Nordoy A, Gjone E. Splenectomy in active chronic hepatitis. Scand J Gastroenterol 1972; 7:747-750
23. William WC. Splenectomy for thrombo-cytopenia due to secondary hypersplenism. Arch Surg 1988; 123:369-371
24. Toghill PJ, Green S. Splenic influences on the blood in chronic liver disease. Q J Med 1979; 48:613-625 (Pubitemid 10210781)
25. Shimada M, Hashizume M, Shirabe K, et al. A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Surg Endosc 2000; 14:127-130
26. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958-965
27. Hisaka T, Yano H, Ogasawara S, et al. Interferona Conl suppresses proliferation of liver cancer cell lines in vitro and in vivo. J Hepatol 2004; 41: 782-789 (Pubitemid 39434308)
28. Akuta N, Suzuki F, Suzuki Y, et al. Long-term follow up of interferon monotherapy in 454 consecutive native patients infected with hepatitis C virus: multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survivial. Scand J Gastroenterol 2005; 40: 688-696
29. Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology 2003; 124: 1711-1719
30. Oh JW, Ahn SM, Kim KS, et al. The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism. Yonsei Med J 2003; 30:1053-1058
31. Lin MC, Wu CC, Ho WL, et al. Concomitant splenectomy for hypersplenic thrombocytopenia in hepatic resection for hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 630-634
32. Chen XP, Wu ZD, Huang ZY, et al. Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg 2005; 92:334-339
33. Akahoshi T, Tomikawa M, Korenaga D, et al. Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism. Surg Endosc 2009 Aug 19. [Epub ahead of print]
34. Morihara D, Kobayashi M, Ikeda K, et al. Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia. Hepatol Res 2009; 39:439-447
35. Megison SM, McMullin ND, Andrews WS. Selective use of splenectomy after liver transplantation in children. J Pediatr Surg 1990; 25: 881-884 (Pubitemid 20255201)
36. Cescon M, Sugawara Y, Takayama T, et al. Role of splenectomy in living-donor liver transplantation for adults. Hepatogastroenterology 2002; 49: 721-723 (Pubitemid 34615336)
37. Sato Y, Yamamoto S, Oya H, et al. Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation. Hepatogastroenterology 2002; 49:1652-1655 (Pubitemid 35277347)
38. Shimada M, Ijichi H, Yonemura Y, et al. The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology 2004; 51:625-629
39. Tashiro H, Itamoto T, Ohdan H, et al. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation? J Gastroenterol Hepatol 2007; 22:959-960
40. Kishi Y, Sugawara Y, Akamatsu N, et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant 2005; 19: 769-772 (Pubitemid 41748730)
41. Geissler I, Lamesch P, Witzigmann H, et al. Spleno-hepatic arterial steal syndrome in liver transplantation:clinical features and management. Transpl Int2002; 15:139-141
42. Liisebrink R, Blumhardt G, Lohmann R, et al. Does concommitant splenectomy raise the mortality of liver transplant recipients? Transpl Int 1994; 7: 634-636
43. Samimi F, Irish WD, Eghtesad B, et al. Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci 1998; 43:1931-1937 (Pubitemid 28436206)
44. Okabayashi T, Hanazaki K. Overwhelming postsplenectomy infection syndrome in adults - A clinical preventable disease. World J Gastroenterol 2008; 14:176-179 (Pubitemid 351320405)
45. Hashizume M, Sugimachi K, Ueno K. Laparoscopic splenectomy with an ultrasonic dissector. N Engl J Med 1992; 327:438
46. Carroll BJ, Phillips EH, Semel CJ, et al. Laparoscopic splenectomy Surg Endosc 1992; 6:183-185
47. Hashizume M, Tomikawa M, Akahoshi T, et al. Laparoscopic splenectomy for portal hypertension. Hepatogastroenterology 2002; 49: 847-852
48. Kercher KW, Matthews BD, Walsh RM, et al. Laparoscopic splenectomy for massive splenomegaly. Am J Surg 2002; 183:192-196
49. Targarona EM, Balague C, Trias M. Hand-assisted laparoscopic splenectomy. Semin Laparosc Surg 2001; 8:126-134
50. Kawanaka H, Akahoshi T, Kinjo N, et al. Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. J Hepatobiliary Pancreat Surg 2009; 16: 749-757
51. Ikegami T, Toshima T, Takeishi K, et al. Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension. J Am Coll Surg 2009; 208: el - 4. Epub 2008 Dec 12.
52. Murata K, Ito K, Yoneda K, et al. Splenectomy im proves liver function in patients with liver cirrhosi. Hepatogastroenterology 2008; 55: 1407-1411
53. Anegawa G, Kawanaka H, Uehara H, et al. Effect of laparoscopic splenectomy on portal hypertensive gastropathy in cirrhotic patients with portal hypertension. J Gastroenterol Hepatol 2009; 24: 1554-1558
54. Shimamura T, Taniguchi M, Jin MB, et al. Excessive portal venous inflow as a cause of allograft dysfunction in small-for-size living donor liver transplantaion. Transplant Proc 2001; 33: 1331 (Pubitemid 32237866)
55. Jeng LB, Lee CC, Chiang HC, et al. Indication for splenectomy in the era of living-donor liver transplantation. Transplant Proc 2008; 40: 2531-2533
56. Ito T, Kiuchi T, Yamamoto H, et al. Changes in portal venous pressure in the early phase after living donor liver transplantatiompathogenesis and clinical implications. Transplantation 2003; 75: 1313-1317 (Pubitemid 36513040)
57. Yamada T, Tanaka K, Uryuhara K, et al. Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transplant 2008; 8: 847-853 (Pubitemid 351347754)
58. Taniguchi M, Shimamura T, Suzuki T, et al. Transient portacaval shunt for a small-for-size graft in living donor liver transplantation. Liver Transpl 2007; 13:932-934 (Pubitemid 46939451)
59. Umeda Y, Yagi T, Sadamori H, et al. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation 2008; 86: 673-680
60. Quintini C, Hirose K, Hashimoto K, et al. "Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphon. Liver Transpl 2008; 14: 374-379
61. Pan Z, Wu XJ, Li JS, et al. Functional hepatic flow in patients with liver cirrhosis. World J Gastroenterol 2004; 10:915-918 (Pubitemid 38418375)
62. Zhang Y, Wen T, Yan L, et al. The changes of hepatic hemodynamics and functional hepatic reserve after splenectomy with periesophagogastric devascularization. Hepatogastroenterology 2009; 56: 835-839
63. Porter BA, Frey CF, Link DP, et al. Splenic embolization monitored by the video dilution technique. AJR 1983; 141: 1063-1065
64. Nagasue N, Dhar DK, Yamanoi A, et al. Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis. Hepatology 2000; 31:1107-1114 (Pubitemid 30233235)
65. Sato Y, Ichida T, Yamamoto S, et al. Shear stress theory and small-for-size graft in adult living related liver transplantation. Transplant Proc 2003; 35:78 (Pubitemid 36194522)
66. Bartoloni St, Omer F. Interdependence between the spleen and liver, studied in hepatic regeneration after partial hepatectomy. Arch De Vecchi Anat Patol 1967; 49: 419-444
67. Ohira M, Umeyama K, Taniura M, et al. An experimental study of a splenic inhibitory factor influencing hepatic regeneration. Surg Gynecol Obstet 1987; 164:438-444 (Pubitemid 17079664)
68. Perez-Tamayo R, Romero R. Role of spleen in regeneration of the liver: an experimental study. Lab Invest 1958; 7: 248-257
69. Ueda S, Yamanoi A, Hishikawa Y, et al. Transforming growth factor-β1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Lab Invest 2003; 83: 1595-1603 (Pubitemid 37421100)
70. Nakamura T, Sakata R, Ueno T, et al. Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000; 32: 247-255 (Pubitemid 30614657)
71. Akahoshi T, Hashizume M, Tanoue K, et al. Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor β-1. J Gastroenterol hepatol 2002; 17: 59-65 (Pubitemid 34304388)
72. Okada Y, Tsuzuki Y, Hokari R, et al. Pressure loading and ethanol exposure differentially modulate rat hepatic stellate cell activation. J Cell Physiol 2008; 215:472-480
73. Kaido T, Yoshikawa A, Okajima A, et al. Expression of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepatogastroenterol 2004; 51: 547-551
74. Murata K, Shiraki K, Sugimoto K, et al. Splenectomy enhances liver regeneration through tumor necrosis factor (TNF)-α following dimethylnitrosamine-induced cirrhotic rat model. Hepatogastroenterology 2001; 48:1022-1027
75. Murata S, Ohkohchi N, Matsuo R, et al. Platelets promote liver regeneration in early period after hepatectomy in mice. World J Surg 2007; 31: 808-816 (Pubitemid 46496239)
76. Lesurtel M, Graf R, Alei B, et al. Platelet-drived serotonin mediates liver regeneration. Science 2006; 312:104-107
77. Fried MW, Shiftman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982
78. Syed E, Rahbin N, Weiland O, et al. Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis. Scand J Gastroenterol 2008; 43:1378-1386
79. Wu CC, Cheng SB, Ho WM, et al. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia. Surgery 2004 136:660-668
80. Sugimachi K, Ikeda Y, Tomikawa M, et al. Appraisal of hepatic resection in the treatment of hepatocellular carcinoma with severe thrombocytopenia. World J Surg 2008; 32:1077-1081
81. Ikai I, Arii S, Okazaki M, et al. Report of the 17th Nationwide Follow-up Survey of primary liver cancer in Japan. Hepatol Res 2007; 37: 676-691 (Pubitemid 47054774)
82. Todo S, Furukawa H, Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451-461
83. Iacobellis A, Siciliano M, Perri F, et al. Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study. J Hepatol 2007; 46: 206-212 (Pubitemid 44959155)
84. Okamura S, Sakai T, Yoshikai H, et al. Case of overwhelming postsplenectomy infection (OPSI) with chronic hepatitis type C during peginterferon/ ribavirin combination therapy. Nippon shokakibyo Gakkai Zasshi 2009; 106: 411-417
85. Wagtorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 2001; 54: 214-218
86. Tasaka T, Nagai M, Ikeda K, et al. Post-splenectomy meningitis in patients with lymphoid malignancy. Intern Med 1992; 31: 1137-1138 (Pubitemid 23012649)
87. Planas R, Ballesté B, Alvarez MA, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004; 40:823-830 (Pubitemid 38507364)
88. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33: 41-48
89. Levi D, Maurifio E, Abecasis R, et al. Splenic hypofunction in cirrhosis is not associated with increased risk for infections. Eur J Gastroenterol Hepatol 1996; 8: 257-260
90. Cao ZX, Chen XP, Wu ZD. Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2003; 2: 562-565
91. CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46: 1-24
92. Stamou KM, Toutouzas KG, Kekis PB, et al. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 2006; 141: 663-639
93. Winslow ER, Brunt LM, Drebin JA, et al. Portal vein thrombosis after splenectomy. Am J Surg 2002; 184:631-636
94. Kawanaka H, Akahoshi T, Kinjo N, et al. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg 2010; 251:76-83
95. Danno K, Ikeda M, Sekimoto M, et al. Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomy. Surgery 2009; 145: 457-464
96. Ikeda M, Sekimoto M, Takiguchi S, et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 2005; 241: 208-216
97. Yoshida H, Mamada Y, Taniai N, et al. Partial splenic embolization. Hepatol Res 2008; 38: 225-233
98. Miyake Y, Ando M, Kaji E, et al. Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Hepatol Res 2008; 38: 980-986
99. Hidaka H, Kokubu S, Nakazawa T, et al. Therapeutic benefits of partial splenic embolization for thrombocytopenia in hepatocellular carcinoma patients treated with radiofrequency ablation. Hepatol Res 2009; 39: 772-778
100. Tomikawa M, Akahoshi T, Sugimachi K, et al.Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol 2009; 19. [Epub ahead of print]
101. Troisi R, Hesse UJ, Decruyenaere J, et al. Functional, life-threatening disorders and splenectomy following liver transplantation. Clin Transplant 1999; 13: 380-388
102. Iinuma H, Okinaga K, Sato S, et al. Optimal site and amount of splenic tissue for autotransplantation. J Surg Res 1992; 53:109-116
103. McHutchison JG, Dusheiko G, Shiftman ML, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med 2007; 357: 2227-2236
104. Bishop MB, Lansing LS. The spleen: A correlative overview of normal and pathological anatomy. Human Pathology 1982; 13: 334-342